Matthew Nowland

Oct 10, 2023 | clinicalleader.com | Charles Chrisawn |Michael Edwards |Matthew Nowland

Get more clinical research insight with our FREE newsletter Article | October 10, 2023 By Charles Chrisawn, Michael Edwards and Matthew Nowland Cancer stands as the foremost global cause of mortality, responsible for nearly one out of every six deaths. Recent research indicates that approximately 15% of cancer-related fatalities could be prevented through early disease detection.

Oct 10, 2023 | cellandgene.com | Charles Chrisawn |Michael Edwards |Matthew Nowland

Article | October 10, 2023 By Charles Chrisawn, Michael Edwards and Matthew Nowland Cancer stands as the foremost global cause of mortality, responsible for nearly one out of every six deaths. Recent research indicates that approximately 15% of cancer-related fatalities could be prevented through early disease detection.

Sep 21, 2023 | clinicalleader.com | Michael Edwards |Matthew Nowland |Charles Chrisawn

Article | September 21, 2023 By Charles Chrisawn, Michael Edwards and Matthew Nowland The development of liquid biopsies for early cancer detection demands meticulous planning. Achieving success in this endeavor relies on a comprehensive grasp of the regulatory landscape and the hurdles involved in conducting the requisite studies for approval.

Mar 20, 2023 | clinicalleader.com | Caroline Perez |Matthew Nowland

Article | March 20, 2023 By Matthew Nowland and Caroline Perez To strengthen its regulations for better patient protection and more effective implementation of the rules for in vitro diagnostic medical devices, the European Union released a five-year in vitro diagnostic regulation (IVDR) transition plan in May 2017.